13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001983313
Total reported value
—
$229.6M
21 檔
34.0%
The Q1 2025 SEC filing reveals that Cutter Capital Management, LP held a total portfolio value of $229.6M, covering 21 public equity positions.
During Q1 2025, Cutter Capital Management, LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 7.83% | — | — | |
| 2 | AMGN | Amgen Inc | Stock-Healthcare | 6.78% | — | +31.27% | |
| 3 | BIIB | Biogen Inc | Stock-Healthcare | 6.76% | — | — | |
| 4 | LLY | Eli Lilly & Co | Stock-Healthcare | 6.47% | — | — | |
| 5 | INSM | Insmed Inc | Stock-Healthcare | 6.19% | — | -11.62% | |
| 6 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 5.98% | — | -6.76% | |
| 7 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 5.88% | — | -30.29% | |
| 8 | PRGO | Perrigo Company plc | Stock-Healthcare | 5.85% | — | +62.81% | |
| 9 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 5.71% | — | — | |
| 10 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.37% | — | +37.09% | |
| 11 | RPRX | Royalty Pharma plc | Stock-Healthcare | 4.84% | — | -53.34% | |
| 12 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 4.59% | — | +82.22% | |
| 13 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 4.42% | — | — | |
| 14 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 3.46% | — | — | |
| 15 | SMMT | Summit Therapeutics Inc | Stock-Other | 3.36% | — | — | |
| 16 | HALO | Halozyme Therapeutics Inc | Stock-Healthcare | 3.33% | — | — | |
| 17 | CYTK | Cytokinetics Inc | Stock-Healthcare | 3.06% | — | — | |
| 18 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 3.00% | — | -21.97% | |
| 19 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 2.62% | — | +184.29% | |
| 20 | RCUS | Arcus Biosciences Inc | Stock-Other | 2.50% | — | — | |
| 21 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 1.97% | — | -34.41% |
According to official SEC Form 13F filings, Cutter Capital Management, LP reported a total U.S. public equity portfolio value of $229.6M across 21 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BMY, AMGN, BIIB) accounted for 34.0% of total reported equity market value during Q1 2025.
During Q1 2025, Cutter Capital Management, LP's top holdings by market value included BMY (7.8%)、AMGN (6.8%)、BIIB (6.8%). The largest single position, BMY, represented 7.8% of total portfolio value.
In Q1 2025, Cutter Capital Management, LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.